Zydus To Expand Takeda Supply Chain Role, Boost US Sales With CVS Tie-Up

ALS, CAPS Candidate In US Trials

A Zydus-Takeda joint venture is expected to supply more raw materials to the Japanese major. Meanwhile, a tie-up with CVS Caremark for the sitagliptin franchise is a boost for Zydus’s US sales while the company focuses R&D efforts on rare diseases like ALS and CAPS

Zydus is developing multiple growth prongs for the US market
Zydus Hopes For US Revenues Boost In 2025 (Shutterstock)

More from India

More from Strategy